One hundred patients who received a competitive neuromuscular blocking agent during anaesthesia were randomly selected for evaluation of neuromuscular function immediately on their arrival in the recovery room. The anaesthetist was not aware that the patient would be evaluated in the recovery room. Neuromuscular function was assessed by a train-of-four (TOF) ratio, and in conscious and co-operative patients by a series of bedside tests of neuromuscular function. Twenty-one patients had a TOF ratio of less than 0.70 and seven patients a TOF ratio of less than 0.60. Bedside tests of neuromuscular function did not reliably detect this defect in neuromuscular transmission. It is concluded that a relatively large number of patients have a defect in neuromuscular transmission on their arrival in the recovery room, and suggested that this reflects the inadequacy of clinical methods used for the administration and antagonism of competitive neuromuscular blocking agents at this institution.
Incomplete antagonism of competitive neuromuscular blockade is a potentially lethal complication in the postoperative period. I Recent studies from Scandinavia, Vi by-Mogensen et al. 2 and Lanmarken et al., J have found a relatively high proportion of patients who had received a competitive neuromuscular blocking agent had evidence of incomplete antagonism of the neuromuscular blockade on their arrival in the recovery room. The relevance of these results to Australian anaesthetic practice is uncertain, because of the possible effect of differences in anaesthetic practice between the countries. The purpose of the present paper is to assess, in an Australian teaching hospital, the degree of recovery from competitive neuromuscular blockade in patients on their arrival in the recovery room. An attempt is also made to determine the efficacy of bedside tests of neuromuscular *F.F.A.R.A.C.S., Assislalll AnaC~lhelisl **AnacSlheti( Registrar function in detecting a defect in neuromuscular transmission, as measured by the train-of-four (TOF) ratio, and to identify possible iatrogenic causes of any such defect in neuromuscular transmission.
PATIENTS AND METHODS
The study was approved by the Hospital Board of Medical Research. Subjects of the study were 100 adult patients who were given a competitive neuromuscular blocking agent during anaesthesia. No patient had any disease or had received any drugs in the perioperative period which are known to interact with competitive neuromuscular blocking agents. There were 58 female and 42 male patients, who ranged in age from 16-84 years (mean 53 years) and weight from 42-95 kilograms (mean 74 kilograms).
Anaesthetic techniques employed were: thiopentone-nitrous oxide-narcotic (22 patients); thiopentone-nitrous oxide-halothane (45 patients); thiopentone-nitrous oxideenflurane (33 patients).
Suxamethonium was used in 42 patients to facilitate intubation. Competitive neuromuscular blocking agents used were: pancuronium (9 patients); alcuronium (59 patients); gallamine (10 patients); d-tubocurarine (19 patients); a combination of agents (3 patients). In no patient was a peripheral nerve stimulator used during the operation. At the termination of surgery the neuromuscular block was reversed with neostigmine and atropine. The anaesthetist was not aware that the patient would be assessed in the recovery room.
On arrival in the recovery room the patient was assessed by one of the authors. The degree of neuromuscular blockade was assessed using a neurophysiological method, the TOF ratio. Measurements were repeated over a one-minute period, with the TOF ratio of the patient being the average of 2 to 3 measurements. Conscious and cooperative patients were then immediately asked to perform a series of bedside clinical tests designed to detect residual curarization (Table 1) . These tests were completed within approximately one minute and all measurements were completed within five minutes of the patient's arrival in the recovery room. In patients with a substantial defect in neuromuscular function the TOF ratio was monitored until it was greater than 0.70. If the patient was also unconscious on arrival in the recovery room, the patient was asked to perform the bedside clinical tests when he or she was conscious with the TOF measurement then immediately repeated. Patients with a TOF ratio of less than 0.60 were administered an additional dose of neostigmine and atropine, if considered appropriate by their anaesthetist.
Relevant anaesthetic details were recorded to identify possible iatrogenic causes of incomplete antagonism of competitive neuromuscular blockade. Statistical analysis was performed using the Chi-squared test.
TABLE I
Bedside test of neuromuscular function I. Ability to sustain a head lift for 5 seconds 2. Assessment of hand grip strength 3. Ability to open eyes widely for 5 seconds 4. Assessment of quality of speaking voice 5. Ability to "touch teeth" 6. Ability to protrude the tongue RESULTS Twenty-one patients had a TOF ratio of less than 0.70 immediately following their arrival in the recovery room, and six patients a TOF ratio of less than 0.60 ( Figure 1 ). Of the six patients with a TOF ratio of less than 0.60, four were given an additional dose of 2.5 mg neostigmine and 1.2 mg atropine, with the recovery to a TOF ratio of greater than 0.70 taking 15-90 minutes. One patient, with a TOF ratio of 0.25, had inadequate ventilation with an increased respiratory rate, use of accessory respiratory muscles, and a SUbjective sensation of dyspnoea.
Sixty-two of the patients co-operated to perform the bedside clinical tests (Table 1) , and, of the remaining patients, 18 were uncooperative and 20 were unconscious. Nine of these 62 patients were unable to sustain a head lift for five seconds (Figure 2 ). Seven patients with a TOF ratio of less than 0.70, including one patient with a TOF ratio of 0.45, could sustain a head lift for five seconds. The clinical tests: hand grip strength, ability to sustain eye opening for five seconds and ability to protrude the tongue had similar results with an inability to reliably differentiate patients with a TOF ratio of less than 0.70 from those with a TOF ratio of greater than 0.70. Combining the results of all four tests only marginally improved the ability of these tests to detect patients with a TOF ratio of less than 0.70; five out of thirteen patients (38 per cent) with a TOF ratio of less than 0.70 still had positive results in three or more tests. The bedside clinical tests of an assessment of the quality of the speaking voice and ability to 'touch teeth' had a negative result in many patients with a TOF ratio of greater than 0.70. This appeared to be due to either the patient not fully comprehending the test or the imprecise end point of the test. None of the anaesthetic factors which were recorded was found to be statistically associated (P<0.05) with a TOF ratio of less than 0.70. These included the anaesthetic technique employed, competitive neuromuscular blocking agent used, the number of doses of neuromuscular blocking agent given, time interval between last dose of neuromuscular blocking agent and reversal, and the dose of neostigmine used for reversal.
The blockade and has been widely advocated for this use. 6 -8 This is a more objective and sensitive method for assessing recovery than clinical observations such as head lift or grip strength. 8 A TOF ratio of 0.70 and higher correlates with clinical signs of adequate recovery from competitive neuromuscular blockade. 9 -11 Using this criteria, 21 out of the 100 patients who had received a competitive neuromuscular blocking agent were judged to have inadequately recovered from the neuromuscular blockade on their arrival in the recovery room. Ventilatory failure secondary to inadequate respiratory muscle function has been considered the main complication of incomplete antagonism of a competitive neuromuscular blockade. 12 However, a TOF ratio of less than 0.70 does not directly equate with inadequate ventilation. The defect in neuromuscuar transmission must be substantial, a TOF ratio of 0.25-0.45 in this study, before the weakness in the respiratory muscles will be sufficient to cause inadequate ventilation in otherwise healthy patients. Therefore what is the basis for categorising patients with a TOF ratio between 0.45 and 0.70 as inadequately recovered? Healthy patients who have a TOF ratio within this range will have sustained spontaneous ventilation even though respiratory muscle function is impaired. 11 However, in patients with preexisting diminished respiratory reserve, for example in patients with obesity or pre-existing lung disease, the impairment to respiratory muscle function may be sufficient to precipitate ventilatory failure. The patient may also be at risk from the administration of certain drugs, such as an aminoglycoside antibiotic, which could potentiate this residual neuromuscular block. 6 In addition the patient may have residual paralysis of other muscle groups. The muscles involved in protecting and maintaining the upper airway are more sensitive to competitive neuromuscular blocking agents than the diaphragm,13 and require a greater degree of recovery before function is fully restored. 14 Residual paralysis of these muscles will occur within this range of recovery, and may cause upper airways obstruction and laryngeal incompetence, which is an important factor in the aetiology of postoperative pulmonary complications. 15 Thus patients with a TOF ratio of less than 0.70 have an increased risk of ventilatory failure and other pulmonary complications.
The overall risk to patients who have received competitive neuromuscular blocking agents from these complications is difficult to determine but may be considerable, especially in those who are prone to these complications. Recent European studies on anaesthetic mortality found that 10 to 17070 of anaestheticrelated deaths were due to postoperative respiratory failure and in one study 34% of the deaths which were totally due to anaesthesia. 16, 17 The most reliable method of avoiding incomplete antagonism of a competitive neuromuscular block is to monitor the magnitude of the neuromuscular block with a peripheral nerve stimulator, to ensure that attempts to antagonise the neuromuscular block are only made when neuromuscular block has recovered to a level at which complete antagonism can be assured. Various physiological monitors including peripheral nerve stimulators were considered by Lunn and Mushin in the report of a recent study into mortality associated with anaesthesia as valuable in certain circumstances and perhaps essential in a few, but not yet a minimum requirement for instrumental monitoring. '8 However, peripheral nerve stimulators are rarely used in any circumstances in Australia. A nerve stimulator may be essential in those patients who are at greater risk from, and/or have a substantially higher incidence of, incomplete antagonism of a competitive neuromuscular blockade. This includes the elderly, the critically ill, those with decreased renal function, neuromuscular disease, obesity, pre-existing lung disease, and those undergoing prolonged surgery.
The finding of this study, of a high incidence of patients having incomplete antagonism of a competitive neuromuscular blockade on their arrival in the recovery room at the Royal Melbourne Hospital, confirms the results of Viby-Mogenson et al. 2 and Lenmarken et al. 3 We believe that these results reflect the inadequacy of clinical methods used in these institutions for the administration and antagonism of competitive neuromuscular blocking agents. When the neuromuscular blockade is not monitored, the degree of blockade is often a matter of speculation at the time of antagonism, and if profound, complete antagonism may not occur. 19 Hence, there is an inherent incidence of incomplete antagonism when only clinical methods are used. This finding highlights the necessity of adequate postanaesthetic superVISIOn and the requirement for monitoring of neuromuscular function in high risk patients.
